28654574Wood K, Byron E, Janisch L, Salgia R, Sharma MRAmerican journal of clinical oncologyAntineoplastic Combined Chemotherapy Protocols; Neoplasm Recurrence, Local; Thymus NeoplasmsAged; Capecitabine; Celecoxib; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Survival RateCapecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol. 2018 10; 41(10):963-966.Am J Clin Oncol2018-10-01T00:00:002018Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsAuthorship 1063174Authorship 1061330.3417610.1708812authors10.2514has subject areaD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD013953Disorders25410.962727Thymus NeoplasmsD008297Physiology1931408600.201617MaleD009364Disorders33613050.61985Neoplasm Recurrence, LocalD011379Procedures74536690.561447PrognosisD015996Concepts & Ideas45518560.724887Survival RateD00006857918310.980778CelecoxibD00006928742950.952268CapecitabineD005500Procedures76836160.590107Follow-Up StudiesD020714Concepts & Ideas902700.919873Maximum Tolerated DoseMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor